Nicholas B Larson
From genome-wide associations to candidate causal variants by statistical fine-mapping
DJ Schaid, W Chen, NB Larson
Nature Reviews Genetics 19 (8), 491-504, 2018
Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares, J Lu, S Zhou, ...
Cell 174 (3), 564-575. e18, 2018
Complementation contributes to transcriptome complexity in maize (Zea mays L.) hybrids relative to their inbred parents
A Paschold, Y Jia, C Marcon, S Lund, NB Larson, CT Yeh, S Ossowski, ...
Genome research 22 (12), 2445-2454, 2012
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2 and RAD51C status
JM Cunningham, MS Cicek, NB Larson, J Davila, C Wang, MC Larson, ...
Scientific reports 4 (1), 1-7, 2014
PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data
NB Larson, BL Fridley
Bioinformatics 29 (15), 1888-1889, 2013
Associations of mitochondrial and nuclear mitochondrial variants and genes with seven metabolic traits
AT Kraja, C Liu, JL Fetterman, M Graff, CT Have, C Gu, LR Yanek, ...
The American Journal of Human Genetics 104 (1), 112-138, 2019
Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set
SN Thibodeau, AJ French, SK McDonnell, J Cheville, S Middha, ...
Nature communications 6 (1), 1-10, 2015
Nonsyntenic genes drive highly dynamic complementation of gene expression in maize hybrids
A Paschold, NB Larson, C Marcon, JC Schnable, CT Yeh, C Lanz, ...
The Plant Cell 26 (10), 3939-3948, 2014
P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)
SJ Bielinski, C Berardi, PA Decker, PS Kirsch, NB Larson, JS Pankow, ...
Atherosclerosis 240 (1), 3-9, 2015
Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
NB Larson, GD Jenkins, MC Larson, RA Vierkant, TA Sellers, CM Phelan, ...
European Journal of Human Genetics 22 (1), 126-131, 2014
Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression
NB Larson, S McDonnell, AJ French, Z Fogarty, J Cheville, S Middha, ...
The American Journal of Human Genetics 96 (6), 869-882, 2015
Improvement in cardiovascular risk prediction with electronic health records
MM Pike, PA Decker, NB Larson, JL St Sauver, PY Takahashi, VL Roger, ...
Journal of cardiovascular translational research 9 (3), 214-222, 2016
A robust e-epidemiology tool in phenotyping heart failure with differentiation for preserved and reduced ejection fraction: the electronic medical records and genomics (eMERGE …
SJ Bielinski, J Pathak, DS Carrell, PY Takahashi, JE Olson, NB Larson, ...
Journal of cardiovascular translational research 8 (8), 475-483, 2015
A kernel regression approach to gene‐gene interaction detection for case‐control studies
NB Larson, DJ Schaid
Genetic epidemiology 37 (7), 695-703, 2013
CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
JL St Sauver, JE Olson, VL Roger, WT Nicholson, JL Black III, ...
Pharmacogenomics and Personalized Medicine 10, 217, 2017
ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis
NB Larson, EJ Bell, PA Decker, M Pike, CL Wassel, MY Tsai, JS Pankow, ...
Atherosclerosis 251, 422-429, 2016
Yield of the RYR2 Genetic Test in Suspected Catecholaminergic Polymorphic Ventricular Tachycardia and Implications for Test Interpretation
JD Kapplinger, KN Pundi, NB Larson, TE Callis, DJ Tester, H Bikker, ...
Circulation: Genomic and Precision Medicine 11 (2), e001424, 2018
Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium
Y Sandoval, SJ Bielinski, LB Daniels, MJ Blaha, ED Michos, AP DeFilippis, ...
Journal of the American College of Cardiology 76 (4), 357-370, 2020
Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis (MESA)
MP Bancks, SJ Bielinski, PA Decker, NQ Hanson, NB Larson, H Sicotte, ...
Metabolism 65 (3), 64-72, 2016
Cohort profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT protocol)
SJ Bielinski, JL St Sauver, JE Olson, NB Larson, JL Black III, SE Scherer, ...
International journal of epidemiology 49 (1), 23-24k, 2020
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20